Nath Bio-Genes (India) Ltd (NATHBIOGEN) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 537291 | NSE: NATHBIOGEN | Agriculture | Small Cap

Nath Bio-Genes Share Price

166.85 2.15 1.31%
as on 14-Nov'25 16:59

Nath Bio-Genes (India) Ltd (NATHBIOGEN) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 537291 | NSE: NATHBIOGEN | Agriculture | Small Cap

DeciZen - make an informed investing decision on Nath Bio-Genes

Based on:

Overall Rating
M-Cap below 500cr. High Risk from low Liquidity Bole Toh

1. Quality

2. Valuation

Undervalued

3. Price Trend

Semi Strong

Nath Bio-Genes (India) stock performance -

Key Ratios
mw4me loader
P/E Ratio (SA):
6.92
Market Cap:
317.1 Cr.
52-wk low:
141.1
52-wk high:
238

Is Nath Bio-Genes (India) Ltd an attractive stock to invest in?

1. Is Nath Bio-Genes (India) Ltd a good quality company?

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Nath Bio-Genes (India) Ltd is a below average quality company.

2. Is Nath Bio-Genes (India) Ltd undervalued or overvalued?

The key valuation ratios of Nath Bio-Genes (India) Ltd's currently when compared to its past seem to suggest it is in the Undervalued zone.

3. Is Nath Bio-Genes (India) Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Semi Strong which suggest that the price of Nath Bio-Genes (India) Ltd is likely to Rise-somewhat in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Nath Bio-Genes:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Nath Bio-Genes (India) Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good

Value Creation

Value Creation Index Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
ROCE % 13.9%9.5%9.2%8.3%9.2%9.8%-7.8%7.1%7.3%7.3%-
Value Creation
Index
0.0-0.3-0.3-0.4-0.3-0.3-1.6-0.5-0.5-0.5-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 162170192231280308278301333362399
Sales YoY Gr.-4.8%12.8%20.5%21.2%9.9%-9.5%8.2%10.4%8.9%-
Adj EPS 8.810.115.520.126.429.3-35.518.321.122.224.1
YoY Gr.-14.7%52.6%30%31.5%10.9%-221.2%NA15.2%5.3%-
BVPS (₹) 75.8189.5246.9267.1293.4322.7285.2301.7321.3341.3360.4
Adj Net
Profit
14.116.229.438.250.255.7-67.534.940.242.346
Cash Flow from Ops. -13.63.3-47-22.99.51.117.138.474.726.8-
Debt/CF from Ops. -4.322.1-0.7-2.57.490.65.52.71.54.2-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales 9.4%5.3%9.2%8.9%
Adj EPS 10.8%-3.4%NA5.3%
BVPS18.2%3.1%6.2%6.2%
Share Price 7.8% -9.5% 0.8% -5.3%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
Return on
Equity %
12.47.67.67.89.49.5-11.76.36.86.76.9
Op. Profit
Mgn %
15.217.121.118.819.621.813.416.315.214.814.1
Net Profit
Mgn %
8.79.615.316.61818.1-24.211.612.111.711.5
Debt to
Equity
0.50.20.10.10.10.20.20.20.20.2-
Working Cap
Days
490500520553552572652600577614666
Cash Conv.
Cycle
262263264280271301360312297299375

Recent Performance Summary

Return on Equity has increased versus last 3 years average to 6.90%

Sales growth is good in last 4 quarters at 22.09%

Sales growth has been subdued in last 3 years 9.18%

Net Profit has been subdued in last 3 years 0.00%

Latest Financials - Nath Bio-Genes (India) Ltd.

Standalone Consolidated
TTM EPS (₹) 24.1 22.4
TTM Sales (₹ Cr.) 399 405
BVPS (₹.) 360.4 357.6
Reserves (₹ Cr.) 666 661
P/BV 0.46 0.47
PE 6.92 7.46
From the Market
52 Week Low / High (₹) 141.10 / 238.00
All Time Low / High (₹) 38.90 / 585.00
Market Cap (₹ Cr.) 317
Equity (₹ Cr.) 19
Face Value (₹) 10
Industry PE 30.2

Management X-Ray of Nath Bio-Genes:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *16.3816.3816.3816.3816.3816.3816.3816.3813.7813.78
* Pledged shares as % of Promoter's holding (%)

Valuation of Nath Bio-Genes - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Event Update

Login/Register to view analysis.

Analyst's Notes

data not found
No data found!

Key Ratios of Nath Bio-Genes

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Sales162170192231280308278301333362
Operating Expenses 137141151188225241241252282310
Manufacturing Costs887088144181162129112139225
Material Costs-201210-25-41-13917-9-84
Employee Cost 14141216192425232730
Other Costs 56454252676779100124139
Operating Profit 25294043556737495052
Operating Profit Margin (%) 15.2%17.1%21.1%18.8%19.6%21.7%13.4%16.3%15.2%14.5%
Other Income 1112222115
Interest 610105791110910
Depreciation 4311133334
Exceptional Items 000000-89031
Profit Before Tax 151730394957-63364244
Tax 1010-214122
Profit After Tax 141629385056-67354042
PAT Margin (%) 8.7%9.6%15.4%16.6%18.0%18.1%-24.2%11.7%12.1%11.6%
Adjusted EPS (₹)8.910.215.520.226.629.3-35.418.521.122.2
Dividend Payout Ratio (%)0%0%0%0%0%7%-6%11%9%9%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25

Equity and Liabilities

Shareholders Fund 121303469508558613542573611649
Share Capital 16161919191919191919
Reserves 105287450489539594523554592630
Minority Interest0000000000
Debt58693258709992104107110
Long Term Debt152001011032
Short Term Debt43493257709992104104108
Trade Payables48443750683543284279
Others Liabilities 3938323234426387117180
Total Liabilities 2664545706487297907407938771,017

Fixed Assets

Gross Block82224228250265267267270274279
Accumulated Depreciation52161718192022252529
Net Fixed Assets 30207211232246247245244249250
CWIP 0000000000
Investments 5555555566
Inventories141130123155204226220208229331
Trade Receivables45528210810710986979489
Cash Equivalents 16452122294387688
Others Assets 4354104126145173180200223253
Total Assets 2664545706487297907407938771,017

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Cash Flow From Operating Activity -143-47-239117387527
PBT 151730394957-63364244
Adjustment 1013105710102131012
Changes in Working Capital -39-26-87-64-45-65-19-1023-28
Tax Paid -000-3-2-0-3-1-0-1
Cash Flow From Investing Activity -17-4-4-20-14-10-20-3-27-4
Capex -7-4-5-22-16-4-1-3-27-8
Net Investments -0-0-0-0-0-0-0-0-10
Others -100021-7-19004
Cash Flow From Financing Activity 3059020616-22-2-10-11
Net Proceeds from Shares 001360000000
Net Proceeds from Borrowing 145-200-000-02-1
Interest Paid -6-10-10-5-7-9-11-10-9-10
Dividend Paid 000000-4-4-4-4
Others 2210-17251225-81314
Net Cash Flow -0539-2317-25343812

Finance Ratio

PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Ratios
ROE (%)12.47.677.627.879.489.51-11.666.316.796.69
ROCE (%)13.859.59.28.289.249.78-7.827.117.347.29
Asset Turnover Ratio0.660.470.370.380.410.410.360.390.40.38
PAT to CFO Conversion(x)-10.19-1.62-0.610.180.02N/A1.091.880.64
Working Capital Days
Receivable Days10210412715014012812811110592
Inventory Days290291242220235256293259240282
Payable Days-9051,3621,554-634-528-1,4721,663744-1,432-262

Nath Bio-Genes (India) Ltd Stock News

Nath Bio-Genes (India) Ltd FAQs

The current trading price of Nath Bio-Genes on 14-Nov-2025 16:59 is ₹166.8.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 13-Nov-2025 the market cap of Nath Bio-Genes stood at ₹317.1.
The latest P/E ratio of Nath Bio-Genes as of 13-Nov-2025 is 6.92.
The latest P/B ratio of Nath Bio-Genes as of 13-Nov-2025 is 0.46.
The 52-week high of Nath Bio-Genes is ₹238.0 and the 52-week low is ₹141.1.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Nath Bio-Genes is ₹398.6 ( Cr.) .

About Nath Bio-Genes (India) Ltd

No data to display
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×